Alendronate is a generic drug that’s prescribed for osteoporosis and Paget’s disease. It’s available as the brand-name drugs Binosto and Fosamax. The cost of alendronate with and without insurance can ...

We eat healthy and exercise as regularly as we can to stay strong and ward off osteoporosis-but should the prescription drug Fosamax be part of our bone-boosting arsenal? Keep reading for a top ...

NEW YORK (Reuters) - Jurors heard sharply different closing arguments on Wednesday in a trial over whether or not Merck & Co's Fosamax drug treatment for osteoporosis caused a Florida woman's jaw ...

The U.S. Supreme Court on Monday denied a petition for a writ of certiorari filed by the drug company Merck Sharp & Dohme Corp., bringing to a close a decade-long legal battle that had stalled ...

A federal judge in New Jersey has dismissed more than 100 lawsuits alleging Merck & Co.'s osteoporosis drug Fosamax causes bone fractures. A federal judge in New Jersey has dismissed more than 100 ...

Plaintiffs who took the generic version of the osteoporosis drug Fosamax are pre-empted by federal law from pursuing litigation against its manufacturers, says an appellate court, in upholding a lower ...

Please provide your email address to receive an email when new articles are posted on . Compared with other first-line osteoporosis treatments, alendronate therapy yielded an increased risk for ...

TRENTON, N.J. -- A federal court invalidated the patent on Friday for Merck & Co.'s second-largest selling drug, the blockbuster osteoporosis treatment Fosamax, in a decision that offers millions of ...

After a long legal fight, Merck has prevailed in hundreds of Fosamax lawsuits, Reuters reports. (Merck) () For more than a decade, Merck has been defending itself against claims its osteoporosis drug ...

NEW YORK, Nov 23 (Reuters) - A Manhattan federal judge has dismissed a lawsuit alleging that Merck & Co's osteoporosis drug Fosamax causes jaw damage, two months after a jury deadlock led to a ...

BOSTON (CBS.MW) -- Amgen Inc. said its new investigational therapy for preventing bone loss has been proven to be even more effective than Merck's blockbuster drug Fosamax in some studies. Amgen AMGN ...